Is desogestrel available in the United States?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Desogestrel Availability in the USA

Desogestrel is available in the United States, but only in combination oral contraceptive formulations with ethinyl estradiol, not as a standalone progestin-only pill.

Available Formulations in the USA

Based on FDA drug labeling, desogestrel is marketed in the United States as:

  • Combined oral contraceptives: Desogestrel 0.15 mg combined with ethinyl estradiol (0.02 mg or 0.01 mg) 1
  • These are available as monophasic formulations containing 21 active tablets plus placebo tablets

Important Distinction: Progestin-Only Pills

The desogestrel-only contraceptive pill (Cerazette®, 0.075 mg) that is widely available in Europe and other countries is NOT available in the United States 2.

In France and other European countries, two types of progestin-only pills are available:

  • Levonorgestrel 0.03 mg (Microval®)
  • Desogestrel 0.075 mg (Cerazette®) 2

However, U.S. guidelines on contraception 3, 4 do not list desogestrel-only pills among available progestin-only contraceptive options in the United States.

Alternative Progestin-Only Options in the USA

If a progestin-only contraceptive is needed, the following are available in the United States 4:

  • Levonorgestrel progestin-only pills (0.75 mg split dose or 1.5 mg single dose for emergency contraception)
  • Etonogestrel implant (Nexplanon®) - notably, etonogestrel is the active metabolite of desogestrel
  • Levonorgestrel IUD (Mirena®)
  • Depot medroxyprogesterone acetate (DMPA) injections

Clinical Context

Desogestrel is a third-generation progestin that has been extensively studied and used in Europe for decades 5, 6. When taken orally, desogestrel is rapidly metabolized to etonogestrel, which is the biologically active compound 1, 7. This same active metabolite (etonogestrel) is available in the U.S. via the contraceptive implant and vaginal ring (NuvaRing®).

The combined desogestrel/ethinyl estradiol formulations available in the U.S. have demonstrated excellent contraceptive efficacy with Pearl indices as low as 0.04 in European studies 6, though they carry the typical risks associated with combined hormonal contraceptives, including increased venous thromboembolism risk compared to second-generation progestins 2, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.